AIM EXAM ARENA β’ 4TH YEAR MBBS
KMU Past Paper Practice
Topic 17 β Menopause, Female Sex Hormones and Contraception
20 A-type Single Best Answer MCQs β’ Context-Rich KMU Professional Examination Practice
MCQ 1
Question:
A 51-year-old woman in the menopausal transition has troublesome vasomotor symptoms and an intact uterus. She is started on systemic estrogen, with a progestogen given only during part of each treatment cycle. Which HRT regimen is being used?
A 51-year-old woman in the menopausal transition has troublesome vasomotor symptoms and an intact uterus. She is started on systemic estrogen, with a progestogen given only during part of each treatment cycle. Which HRT regimen is being used?
Options:
Estrogen-only therapy
Sequential combined therapy
Continuous estrogen therapy
Continuous combined therapy
Local estrogen therapy
Correct Answer: Sequential combined therapy
Explanation: In sequential HRT, estrogen is given continuously or cyclically while the progestogen is added for only part of each cycle, commonly producing withdrawal bleeding.
MCQ 2
Question:
A 58-year-old woman with an intact uterus completed menopause several years ago. She requires systemic hormone therapy and wishes to avoid predictable monthly withdrawal bleeding. Which regimen best matches this preference?
A 58-year-old woman with an intact uterus completed menopause several years ago. She requires systemic hormone therapy and wishes to avoid predictable monthly withdrawal bleeding. Which regimen best matches this preference?
Options:
Cyclic estrogen alone
Local vaginal estrogen alone
Sequential estrogen-progestogen therapy
Continuous combined estrogen-progestogen therapy
Intermittent progestogen alone
Correct Answer: Continuous combined estrogen-progestogen therapy
Explanation: Continuous combined HRT supplies both hormones continuously and is designed to avoid regular withdrawal bleeding after the initial adjustment period.
MCQ 3
Question:
A postmenopausal woman taking oral systemic estrogen develops recurrent biliary symptoms. Which pharmacological property of oral estrogen contributes to this adverse effect?
A postmenopausal woman taking oral systemic estrogen develops recurrent biliary symptoms. Which pharmacological property of oral estrogen contributes to this adverse effect?
Options:
Prominent first-pass hepatic exposure
Selective progesterone receptor blockade
Direct inhibition of ovarian aromatase
Reduced enterohepatic hormone recycling
Rapid renal elimination of estrogen
Correct Answer: Prominent first-pass hepatic exposure
Explanation: Oral estrogen reaches the liver in high concentration after absorption and alters hepatic protein and biliary physiology, contributing to gallbladder-related adverse effects.
MCQ 4
Question:
A woman with anovulatory infertility receives a drug that reduces estrogenic negative feedback at the hypothalamus, causing an increase in endogenous gonadotropin secretion. Which drug produces this effect?
A woman with anovulatory infertility receives a drug that reduces estrogenic negative feedback at the hypothalamus, causing an increase in endogenous gonadotropin secretion. Which drug produces this effect?
Options:
Fulvestrant
Medroxyprogesterone
Clomiphene
Ethinyl estradiol
Levonorgestrel
Correct Answer: Clomiphene
Explanation: Clomiphene blocks estrogen feedback at the hypothalamus, increasing FSH and LH secretion and thereby promoting follicular development and ovulation.
MCQ 5
Question:
A patient with hormone-sensitive breast malignancy receives a drug that binds the estrogen receptor and promotes degradation and down-regulation of that receptor. Which agent has this mechanism?
A patient with hormone-sensitive breast malignancy receives a drug that binds the estrogen receptor and promotes degradation and down-regulation of that receptor. Which agent has this mechanism?
Options:
Estradiol
Clomiphene
Progesterone
Tamoxifen
Fulvestrant
Correct Answer: Fulvestrant
Explanation: Fulvestrant is an estrogen-receptor antagonist that promotes receptor down-regulation, reducing estrogen-mediated transcription in responsive tissues.
MCQ 6
Question:
A pharmacology student compares agonists and antagonists of female gonadal hormones. Which drug acts principally by antagonizing progesterone receptors?
A pharmacology student compares agonists and antagonists of female gonadal hormones. Which drug acts principally by antagonizing progesterone receptors?
Options:
Raloxifene
Mifepristone
Estriol
Norethindrone
Medroxyprogesterone
Correct Answer: Mifepristone
Explanation: Mifepristone blocks progesterone receptors, whereas norethindrone and medroxyprogesterone act primarily as progestational agonists.
MCQ 7
Question:
A woman with acne is prescribed a contraceptive containing a progestin selected partly because it has antiandrogenic and anti-mineralocorticoid activity. Which progestin has these additional properties?
A woman with acne is prescribed a contraceptive containing a progestin selected partly because it has antiandrogenic and anti-mineralocorticoid activity. Which progestin has these additional properties?
Options:
Progesterone
Norethindrone
Levonorgestrel
Drospirenone
Medroxyprogesterone
Correct Answer: Drospirenone
Explanation: Drospirenone is a progestin with additional antiandrogenic and anti-mineralocorticoid activity, distinguishing it from several older progestins.
MCQ 8
Question:
A clinician explains why unmodified natural progesterone historically required special formulations for effective oral therapy. Which pharmacokinetic feature is primarily responsible?
A clinician explains why unmodified natural progesterone historically required special formulations for effective oral therapy. Which pharmacokinetic feature is primarily responsible?
Options:
Rapid hepatic metabolism after oral administration
Irreversible binding to plasma albumin
Failure to cross intestinal membranes
Complete renal excretion before absorption
Inability to bind intracellular receptors
Correct Answer: Rapid hepatic metabolism after oral administration
Explanation: Natural progesterone undergoes extensive hepatic metabolism, giving it limited oral bioavailability unless specially formulated.
MCQ 9
Question:
During a pharmacology viva, a student is asked to classify medroxyprogesterone acetate according to its structural relationship. Which classification is most appropriate?
During a pharmacology viva, a student is asked to classify medroxyprogesterone acetate according to its structural relationship. Which classification is most appropriate?
Options:
Conjugated estrogen preparation
19-nortestosterone derivative
Progesterone-related progestin
Selective estrogen receptor modulator
Non-steroidal estrogen analogue
Correct Answer: Progesterone-related progestin
Explanation: Medroxyprogesterone acetate belongs to the progesterone/17-hydroxyprogesterone-related group of synthetic progestins.
MCQ 10
Question:
A student groups norethindrone and levonorgestrel together while revising progestin pharmacology. Which structural class contains both drugs?
A student groups norethindrone and levonorgestrel together while revising progestin pharmacology. Which structural class contains both drugs?
Options:
Natural progesterones
Conjugated estrogens
17-hydroxyprogesterone derivatives
Non-steroidal estrogen analogues
19-nortestosterone derivatives
Correct Answer: 19-nortestosterone derivatives
Explanation: Norethindrone and levonorgestrel are synthetic 19-nortestosterone-derived progestins commonly used in hormonal contraception.
MCQ 11
Question:
A woman is given an oral contraceptive pack in which every active tablet contains the same amounts of estrogen and progestin. How should this formulation be classified?
A woman is given an oral contraceptive pack in which every active tablet contains the same amounts of estrogen and progestin. How should this formulation be classified?
Options:
Biphasic preparation
Monophasic preparation
Triphasic preparation
Progestin-only preparation
Sequential HRT preparation
Correct Answer: Monophasic preparation
Explanation: Monophasic combined pills provide the same estrogen-progestin dose in each active tablet, unlike multiphasic preparations in which hormone proportions change.
MCQ 12
Question:
A 26-year-old woman seeks contraception and also reports painful, relatively heavy regular menstrual periods. She has no contraindication to estrogen-containing contraception. Which additional benefit is most relevant when discussing combined oral pills?
A 26-year-old woman seeks contraception and also reports painful, relatively heavy regular menstrual periods. She has no contraindication to estrogen-containing contraception. Which additional benefit is most relevant when discussing combined oral pills?
Options:
Permanent cessation of ovulation
Protection against all genital infections
Elimination of future menopausal symptoms
Reduction in menstrual loss and dysmenorrhea
Prevention of all ovarian disorders
Correct Answer: Reduction in menstrual loss and dysmenorrhea
Explanation: Combined oral contraceptives stabilize the endometrium and suppress ovarian cycling, commonly reducing menstrual blood loss and menstrual pain.
MCQ 13
Question:
A woman asks whether long-term combined oral contraceptive use has any recognized non-contraceptive effect on future gynecological cancer risk. Which statement best reflects the expected effect?
A woman asks whether long-term combined oral contraceptive use has any recognized non-contraceptive effect on future gynecological cancer risk. Which statement best reflects the expected effect?
Options:
Reduced risk of endometrial and ovarian carcinoma
Reduced risk of every genital tract malignancy
Increased risk of ovarian carcinoma only
Increased risk of endometrial carcinoma only
No recognized effect on these cancers
Correct Answer: Reduced risk of endometrial and ovarian carcinoma
Explanation: Suppression of repeated ovulation and controlled endometrial exposure contribute to a recognized reduction in ovarian and endometrial cancer risk.
MCQ 14
Question:
A 40-year-old woman requests combined oral contraception. Repeated measurements show markedly elevated blood pressure despite treatment. Which feature of the combined pill makes this history particularly important?
A 40-year-old woman requests combined oral contraception. Repeated measurements show markedly elevated blood pressure despite treatment. Which feature of the combined pill makes this history particularly important?
Options:
Its tendency to produce permanent ovarian failure
Its ability to suppress endometrial proliferation
Its estrogen-associated arterial vascular risk
Its reduction of menstrual blood loss
Its effect on cervical mucus viscosity
Correct Answer: Its estrogen-associated arterial vascular risk
Explanation: Severe or uncontrolled hypertension increases baseline arterial vascular risk, making estrogen-containing contraception inappropriate because estrogen can further increase thrombotic vascular risk.
MCQ 15
Question:
A woman chooses a copper intrauterine device for long-term contraception. Which biological effect accounts most directly for its contraceptive efficacy?
A woman chooses a copper intrauterine device for long-term contraception. Which biological effect accounts most directly for its contraceptive efficacy?
Options:
Suppression of pituitary FSH secretion
Inhibition of the mid-cycle LH surge
Systemic progesterone receptor activation
Permanent blockage of the fallopian tubes
Local impairment of sperm function and fertilization
Correct Answer: Local impairment of sperm function and fertilization
Explanation: Copper produces a local intrauterine environment that impairs sperm viability and function, markedly reducing the probability of fertilization.
MCQ 16
Question:
A levonorgestrel-releasing intrauterine system is inserted for long-term contraception. Which local effect contributes most importantly to prevention of pregnancy?
A levonorgestrel-releasing intrauterine system is inserted for long-term contraception. Which local effect contributes most importantly to prevention of pregnancy?
Options:
Stimulation of endometrial proliferation
Cervical mucus thickening with endometrial suppression
Increased gonadotropin secretion
Enhanced sperm transport through the cervix
Increased tubal contractility
Correct Answer: Cervical mucus thickening with endometrial suppression
Explanation: Locally released levonorgestrel makes cervical mucus poorly penetrable to sperm and markedly suppresses the endometrium.
MCQ 17
Question:
A woman receiving repeated depot medroxyprogesterone injections initially develops irregular bleeding and later becomes amenorrheic. Which tissue change best explains the later bleeding pattern?
A woman receiving repeated depot medroxyprogesterone injections initially develops irregular bleeding and later becomes amenorrheic. Which tissue change best explains the later bleeding pattern?
Options:
Persistent endometrial hyperplasia
Repeated endometrial ovulation
Progressive cervical epithelial proliferation
Progressive endometrial atrophy
Increasing ovarian estrogen secretion
Correct Answer: Progressive endometrial atrophy
Explanation: Sustained progestin exposure suppresses endometrial growth; with prolonged DMPA use the endometrium becomes thin and atrophic, producing amenorrhea in many users.
MCQ 18
Question:
A woman considering a levonorgestrel subdermal implant asks about complications that are specific to the method of drug delivery rather than to systemic progestin effects. Which complication best fits this description?
A woman considering a levonorgestrel subdermal implant asks about complications that are specific to the method of drug delivery rather than to systemic progestin effects. Which complication best fits this description?
Options:
Local insertion or removal difficulty
Estrogen-induced venous thrombosis
Gallstone formation from oral estrogen
Permanent ovarian destruction
Endometrial hyperplasia from unopposed estrogen
Correct Answer: Local insertion or removal difficulty
Explanation: Subdermal implants require a minor procedure, so local insertion-site problems or difficulty with removal are delivery-specific complications.
MCQ 19
Question:
A primary-care team provides counseling to a couple who wish to delay their next pregnancy. The clinician discusses temporary and permanent methods and allows them to select a method according to their reproductive goals. Which broader concept is best represented by this approach?
A primary-care team provides counseling to a couple who wish to delay their next pregnancy. The clinician discusses temporary and permanent methods and allows them to select a method according to their reproductive goals. Which broader concept is best represented by this approach?
Options:
Population screening
Hormone replacement
Family planning
Infertility treatment
Menopausal management
Correct Answer: Family planning
Explanation: Family planning enables individuals and couples to make informed decisions about the number and spacing of children using acceptable reproductive methods.
MCQ 20
Question:
A community medicine team is comparing contraceptive prevalence between two surveys. One survey reports current contraceptive use among all women of reproductive age, while the other reports use only among married or in-union women. What information is essential before comparing the reported rates?
A community medicine team is comparing contraceptive prevalence between two surveys. One survey reports current contraceptive use among all women of reproductive age, while the other reports use only among married or in-union women. What information is essential before comparing the reported rates?
Options:
Average age at menopause
Number of contraceptive brands available
Proportion using hormonal methods only
Average duration of contraceptive use
Population used as the denominator
Correct Answer: Population used as the denominator
Explanation: CPR depends on the defined population in the denominator; rates using all reproductive-age women cannot be interpreted identically to rates restricted to married or in-union women.
